Diversified Healthcare Trust (DHC) Cost of Revenue (2024 - 2026)

Diversified Healthcare Trust has reported Cost of Revenue for 3 years, with the latest figure at $62.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 7.18% year-over-year to $62.1 million; the trailing twelve-month figure through Mar 2026 stood at $289.3 million (up 7.84% YoY), and the FY2025 full-year result was $318.1 million, changed 0.25% from the prior year.
• Cost of Revenue for Q1 2026 stood at $62.1 million, down from $78.2 million in the prior quarter.
• The five-year high for Cost of Revenue was $124.1 million in Q4 2024, with the low at $12.6 million in Q1 2024.
• Historically, Cost of Revenue has averaged $63.4 million across 3 years, with a median of $66.9 million in 2025.
• The largest YoY upside for Cost of Revenue was 435.95% in 2025 against a maximum downside of 37.0% in 2025.
• Diversified Healthcare Trust's Cost of Revenue stood at $124.1 million in 2024, then slumped by 37.0% to $78.2 million in 2025, then slipped by 20.65% to $62.1 million in 2026.
• The last three Cost of Revenue figures came in at $62.1 million (Q1 2026), $78.2 million (Q4 2025), and $69.8 million (Q3 2025), per Business Quant data.